BioAtla

IPO

BioAtla was founded in 2007, is headquartered in San Diego, United States, lists 51–200 employees, and has $112.5M in recorded funding across 2 rounds.

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$112.5M
Last Round
$40.0M Corporate RoundDec 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using its proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!) platforms. These technologies, protected by more than 700 issued patents and patent applications, allow the company to develop novel biologics that are safer and more effective by more selectively targeting cancer tissue and improving manufacturability. Improved selectivity for the tumor microenvironment expands the universe of potential drug targets, enabling treatment of previously untreatable cancers.

Summary

BioAtla is a Biotech company based in San Diego, United States, founded in 2007. It lists 51–200 employees. It has raised $112.5M in total across 2 rounds, most recently a $40.0M Corporate Round in Dec 2025. Investors include Soleus Capital, HBM Healthcare Investments and Cormorant Asset Management.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Corporate RoundCorporate RoundDec 2025
$40.0M

Sign up to see all 3 events

Funding: Series D through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioAtla on Indexed.vc
<a href="https://indexed.vc/companies/bioatla"><img src="https://indexed.vc/api/badge/company/bioatla" alt="BioAtla on Indexed.vc" width="260" height="76" /></a>